Full-Time

Data Strategy Partner

Posted on 4/17/2025

IQVIA

IQVIA

10,001+ employees

Analytics and research for life sciences

Compensation Overview

$134.2k - $290.8k/yr

+ Incentive Plans + Bonuses

Senior

Company Historically Provides H1B Sponsorship

Parsippany-Troy Hills, NJ, USA

Candidates should ideally be based in the US, particularly in New Jersey.

Category
Strategy Development
Business Development
Business & Strategy
Required Skills
Data Analysis
Requirements
  • Bachelor's Degree required
  • 5-8 years of experience in healthcare information and/or commercial operations preferred
  • Expertise in IQVIA US Data sets, including DDD, Plantrack, Syndicated data (sub-national), Rx sales, patient data, Sales data, Xponent, FIA/LAAD
  • Ability to aggregate and utilize data effectively for business use cases
  • Strong understanding of how to process and leverage eLAAD data to create new use cases
  • Proficiency in data analytics techniques and tools to drive data-driven decision-making
  • Excellent client engagement skills, with a focus on changing perspectives and driving customer-centric solutions
  • Proven ability to drive strategic business development and achieve sales targets
Responsibilities
  • Drive the integration and coordination of global data, ensuring seamless delivery and identifying new analytics use cases
  • Engage with senior stakeholders to understand and address their business needs, leveraging a deep understanding of various US data sets (national, subnational, patient data, etc.)
  • Partner closely with US RBU leads to ensure global data integration and analytics
  • Develop and nurture long-term relationships with key Commercial Operations stakeholders, acting as their trusted advisor
  • Achieve financial and strategic growth goals by defending, maintaining, and growing our Information Solutions offerings
  • Create high-value information solutions for client use cases, leveraging both new and existing Commercial Operations investments
  • Utilize advanced data analytics techniques to aggregate, analyze, and interpret various US data sets, providing actionable insights and driving data-driven decision-making

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their main product, IQVIA Connected Intelligence™, utilizes big data and technology to offer insights that help clients speed up the development and marketing of new medical treatments. This system connects various healthcare data points to provide a comprehensive view of patient care and treatment effectiveness. Unlike many competitors, IQVIA places a strong emphasis on patient privacy, using advanced technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in their efforts to understand diseases and improve treatment options.

Company Size

10,001+

Company Stage

IPO

Headquarters

Durham, North Carolina

Founded

1998

Simplify Jobs

Simplify's Take

What believers are saying

  • AI-driven patient engagement tools improve healthcare experiences and outcomes.
  • Blockchain in clinical trials enhances data security and transparency.
  • Real-world evidence use in regulatory submissions boosts demand for IQVIA's analytics services.

What critics are saying

  • Competition from AI-driven solutions by companies like Nvidia may impact market share.
  • Rapid medical innovation may strain IQVIA's resources for timely guidance.
  • Med-R1 8B adoption may face challenges against larger competitor models.

What makes IQVIA unique

  • IQVIA's Med-R1 8B LLM outperforms larger models in medical reasoning tasks.
  • Site Lab Navigator automates lab workflows, enhancing clinical trial efficiency.
  • IQVIA's AI Assistant won the 2024 PM360 Innovation Award for AI.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Life Insurance

Flexible Work Hours

Paid Vacation

Wellness Program

401(k) Retirement Plan

Company News

BioPharmaTrend
Apr 7th, 2025
IQVIA Introduces a Compact Medical Reasoning LLM Outscoring Larger Models

IQVIA has launched Med-R1 8B, a medical reasoning large language model (LLM) designed to assist healthcare professionals in interpreting complex clinical data and scientific literature.

PR Newswire
Mar 26th, 2025
'Business Of Life Sciences And Healthcare For Leaders' Forthcoming From Umd Smith Executive Education

COLLEGE PARK, Md., March 26, 2025 /PRNewswire/ -- Registration is open for "Business of Life Sciences and Healthcare for Leaders" (B-LSHC) — an immersive five-day program focused on leadership development and honing critical-thinking and problem-solving skills in medical product development presented by Smith Executive Education at the University of Maryland's Robert H. Smith School of Business.The in-person program takes place June 23-27, 2025, at Van Munching Hall on UMD's College Park campus and is designed for mid-to-advanced career professionals in the LSHC ecosystem including pharmaceutical, biotech and medical device industries; health policy; patient advocacy; regulators; investors; and leaders across medical and regulatory fields.Program sessions will begin at 8:30 a.m. each day "and end with a luminary keynote speaker who will inspire and challenge participants to think outside the box toward the goals of creating innovative solutions for some of our most challenging problems in the LSHC ecosystem," says Wendy Sanhai, PhD, professor of the practice in management and organization for the Smith School and one of the workshop's organizers.Participants will learn from world-renowned faculty, regulatory experts and industry leaders on how to make informed decisions at crucial stages of medical product (drugs, biologics and medical devices) development – from R&D and regulatory submission to commercial launch and reimbursement. And, through expert-led sessions, dynamic capstone project discussions and case-study analysis, participants will sharpen their problem-solving and critical-thinking skills as they expand their professional network.Instructors, in addition to Sanhai, will include UMD and Smith faculty experts Balaji Padmanabhan, director of Smith's Center for Artificial Intelligence in Business; management and organization professors Jennifer Carson Marr, Oliver Schlake and Subra Tangirala; marketing professor Judy Frels; School of Public Health Dean Boris Lushniak; and School of Pharmacy Professor Joga Gobburu.The UMD experts will be joined by leading industry experts including former CEO of Scorpion Therapeutics Axel Hoos, IntoValue CEO Marion Couch, Deloitte Principals Juergen Klenk, Candy Lurken and Mathias Cousin; Euclidean Life Science Advisors President Kenneth Moch; Licensing IP negotiator Steve Ferguson; leaders from IQVIA and former FDA leaders.Participants will:Sharpen problem-solving, leadership and critical-thinking skillsCultivate holistic thinking and multidisciplinary approaches for real-world problems in the LSHC ecosystemBuild upon lessons learned and best practices from regulatory experts, industry luminaries and academic leadersExpand their professional networkIdentify major milestones, potential challenges, risks and mitigation strategies across medical product development pathways in R&D, regulatory submission, product launch and commercializationExecute critical steps in license negotiations and technology transfer processesParticipants should have at least a bachelor's degree and five years of working experience in any LSHC field.Scholarships are available, including for nonprofits, government professionals and veterans. Discounts are available for organizations with multiple participants. Information sessions via Zoom are set for 1-2 p.m

HR Tech Wire
Mar 10th, 2025
IQVIA recognized as a leader in IDC MarketScape's 2024 assessment for decentralized clinical trial technologies and consulting services

IQVIA (NYSE:IQV), a leading global provider of AI-powered analytics, technology solutions and clinical research services to the healthcare and life sciences industries, has been named to the "Leaders" category of the IDC MarketScape: Worldwide Life Science R&D Decentralized Clinical Trial Technology Solutions and Consulting Services 2024 Vendor Assessment.

Life Sciences British Columbia
Mar 4th, 2025
IQVIA Laboratories Launches Site Lab Navigator with Breakthrough e-Requisition Innovation to Transform Clinical Trials

IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials.

IQVIA
Mar 4th, 2025
IQVIA Laboratories launches Site Lab Navigator with breakthrough e-Requisition innovation to transform clinical trials

RESEARCH TRIANGLE PARK, N.C. - March 4, 2025 - IQVIA Laboratories, a leading global drug discovery and development laboratory services organization, announces the launch of Site Lab Navigator, an advanced suite of solutions that automates and streamlines lab workflows for clinical trial sponsors and investigator sites.